Mezzion Pharma Co.,Ltd. (KOSDAQ: 140410)

Mezzion Pharma Co.,Ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	19,727	40,246	29,399	24,210	35,854	15,644
Short-Term Investments	15,000	18,000	3,000	23,284	13,250	20,500
Trading Asset Securities	-	-	-	-	-	5,015
Cash & Short-Term Investments	34,727	58,246	32,399	47,494	49,104	41,159
Cash Growth	-46.16%	79.78%	-31.78%	-3.28%	19.30%	-31.86%
Accounts Receivable	1,376	2,309	2,644	2,368	2,565	2,867
Other Receivables	319.54	2,154	238.76	377.57	223.51	281.5
Receivables	2,305	5,925	4,203	4,435	4,248	4,200
Inventory	5,493	5,742	8,835	11,777	7,011	6,003
Prepaid Expenses	122.66	136.44	265.05	266.77	238.94	252.15
Other Current Assets	7,681	4,194	195.28	201.3	66.81	235.1
Total Current Assets	50,330	74,244	45,897	64,174	60,669	51,849
Property, Plant & Equipment	2,822	2,854	4,245	4,879	5,899	4,902
Long-Term Investments	2.69	7.46	-	-0	0	-0
Other Intangible Assets	1,620	1,620	1,620	1,620	1,620	1,620
Long-Term Deferred Charges	18,668	11,324	-	12,559	6,622	-
Other Long-Term Assets	693.05	1,951	1,950	672.93	656.16	472.46
Total Assets	74,236	92,149	54,022	83,935	75,625	58,874
Accounts Payable	1,827	4,030	7,173	5,503	3,466	3,574
Accrued Expenses	16,709	-	-	7,188	5,533	7,850
Short-Term Debt	-	499.58	1,063	932.01	985.5	424.62
Current Portion of Leases	651.03	-	-	1,051	1,015	753.33
Current Income Taxes Payable	-	-	-	-	803.65	76.95
Other Current Liabilities	359.49	25,086	17,844	3,823	3,711	831.08
Total Current Liabilities	19,547	29,615	26,080	18,497	15,514	13,510
Long-Term Leases	812.11	-	-	2,338	3,104	2,420
Other Long-Term Liabilities	89.92	1,090	1,702	89.78	88.78	0
Total Liabilities	20,473	30,705	27,782	21,141	18,816	16,044
Common Stock	14,979	14,804	13,371	4,451	4,446	4,353
Additional Paid-In Capital	158,835	150,510	99,256	107,802	107,530	82,963
Retained Earnings	-131,629	-123,723	-111,052	-74,789	-61,166	-47,351
Comprehensive Income & Other	11,578	19,854	24,665	25,330	5,999	2,865
Shareholders' Equity	53,763	61,444	26,240	62,793	56,810	42,830
Total Liabilities & Equity	74,236	92,149	54,022	83,935	75,625	58,874
Total Debt	1,463	499.58	1,063	4,321	5,104	3,597
Net Cash (Debt)	33,264	57,747	31,336	43,173	44,000	37,562
Net Cash Growth	-45.15%	84.28%	-27.42%	-1.88%	17.14%	-37.57%
Net Cash Per Share	1116.89	2044.93	1172.20	1617.75	1692.10	1446.12
Filing Date Shares Outstanding	29.96	29.61	26.74	26.7	26.68	26.12
Total Common Shares Outstanding	29.96	29.61	26.74	26.7	26.68	26.12
Working Capital	30,783	44,628	19,817	45,678	45,155	38,339
Book Value Per Share	1794.56	2075.31	981.23	2351.55	2129.45	1639.88
Tangible Book Value	52,143	59,825	24,620	61,174	55,190	41,210
Tangible Book Value Per Share	1740.49	2020.60	920.66	2290.89	2068.74	1577.86
Buildings	-	-	23.97	23.97	7.97	-
Machinery	-	1,976	3,523	2,908	2,652	2,684
Construction In Progress	-	619.69	439.17	193.43	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.